Fumarate reductase: structural and mechanistic insights from the catalytic reduction of 2-methylfumarate.
Caroline Wardrope, Christopher G Mowat, Malcolm D Walkinshaw, Graeme A Reid, Stephen K Chapman
Index: FEBS Lett. 580(6) , 1677-80, (2006)
Full Text: HTML
Abstract
The soluble fumarate reductase (FR) from Shewanella frigidimarina can catalyse the reduction of 2-methylfumarate with a k(cat) of 9.0 s(-1) and a K(M) of 32 microM. This produces the chiral molecule 2-methylsuccinate. Here, we present the structure of FR to a resolution of 1.5 A with 2-methylfumarate bound at the active site. The mode of binding of 2-methylfumarate allows us to predict the stereochemistry of the product as (S)-2-methylsuccinate. To test this prediction we have analysed the product stereochemistry by circular dichroism spectroscopy and confirmed the production of (S)-2-methylsuccinate.
Related Compounds
Related Articles:
Highly sensitive GC/MS/MS method for quantitation of amino and nonamino organic acids.
2011-04-01
[Anal. Chem. 83(7) , 2705-11, (2011)]
2015-01-01
[J. Pharmacol. Exp. Ther. 352(1) , 90-7, (2015)]
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
2013-10-25
[Neurosci. Lett. 555 , 165-70, (2013)]
In vitro pharmacokinetics of anti-psoriatic fumaric acid esters.
2004-10-12
[BMC Pharmacol. 4 , 22, (2004)]
The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist.
2008-10-31
[Biochem. Biophys. Res. Commun. 375(4) , 562-5, (2008)]